NasdaqCM - Nasdaq Real Time Price • USD
NeuroBo Pharmaceuticals, Inc. (NRBO)
As of April 24 at 4:00 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -1.1 | -0.84 | -3.5 | -2.22 |
| Low Estimate | -1.25 | -0.95 | -3.83 | -2.59 |
| High Estimate | -0.95 | -0.73 | -3.17 | -1.85 |
| Year Ago EPS | -0.77 | -0.16 | -2.46 | -3.5 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -5.04 | -1.01 | -0.86 | -0.78 |
| EPS Actual | -0.77 | -0.16 | -0.72 | -2.28 |
| Difference | 4.27 | 0.85 | 0.14 | -1.5 |
| Surprise % | 84.70% | 84.20% | 16.30% | -192.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.1 | -0.84 | -3.5 | -2.22 |
| 7 Days Ago | -1.25 | -0.73 | -3 | -1.9 |
| 30 Days Ago | -0.96 | -0.89 | -3.26 | -2.49 |
| 60 Days Ago | -0.96 | -0.89 | -3.26 | -2.49 |
| 90 Days Ago | -0.96 | -0.9 | -3.26 | -2.49 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | NRBO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -42.90% | -- | -- | 1.50% |
| Next Qtr. | -425.00% | -- | -- | 11.40% |
| Current Year | -42.30% | -- | -- | 5.20% |
| Next Year | 36.60% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
VRAX Virax Biolabs Group Limited
0.7020
+7.83%
KPRX Kiora Pharmaceuticals, Inc.
0.4800
-5.10%
REVB Revelation Biosciences, Inc.
2.0900
0.00%
ADTX Aditxt, Inc.
2.3100
-2.53%
ENSC Ensysce Biosciences, Inc.
0.5596
+0.18%
SPRC SciSparc Ltd.
1.2000
-0.83%
VRPX Virpax Pharmaceuticals, Inc.
3.1700
+2.59%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.7850
-1.38%
RNAZ TransCode Therapeutics, Inc.
0.4399
0.00%
ALGS Aligos Therapeutics, Inc.
0.8290
0.00%